Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region.

MLA

Ruge, Maximilian I., et al. “Stereotactic Iodine-125 Brachytherapy for the Treatment of WHO Grades II and III Gliomas Located in the Central Sulcus Region.” Neuro-Oncology, vol. 15, no. 12, Dec. 2013, pp. 1721–31. EBSCOhost, https://doi.org/10.1093/neuonc/not126.

APA

Ruge, M. I., Kickingereder, P., Grau, S., Dorn, F., Galldiks, N., Treuer, H., & Sturm, V. (2013). Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region. Neuro-Oncology, 15(12), 1721–1731. https://doi.org/10.1093/neuonc/not126

Chicago

Ruge, Maximilian I, Philipp Kickingereder, Stefan Grau, Franziska Dorn, Norbert Galldiks, Harald Treuer, and Volker Sturm. 2013. “Stereotactic Iodine-125 Brachytherapy for the Treatment of WHO Grades II and III Gliomas Located in the Central Sulcus Region.” Neuro-Oncology 15 (12): 1721–31. doi:10.1093/neuonc/not126.